Publication

Byline

Location

US Patent Issued to TORAY INDUSTRIES on Sept. 1 for "Therapeutic or prophylactic agent for cachexia accompanied by ghrelin resistance" (Japanese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,845, issued on Sept. 1, was assigned to TORAY INDUSTRIES Inc. (Tokyo). "Therapeutic or prophylactic agent for cachexia accompanied by ghrel... और पढ़ें


US Patent Issued to SUVEN LIFE SCIENCES on Sept. 1 for "Methods for treating behavioral and psychological symptoms in patients with dementia" (Indian Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,846, issued on Sept. 1, was assigned to SUVEN LIFE SCIENCES Ltd. (Hyderabad-Telangana, India). "Methods for treating behavioral and psychol... और पढ़ें


US Patent Issued to Disc Medicine on Sept. 1 for "Methods of treating erythropoietic protoporphyria, x-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,847, issued on Sept. 1, was assigned to Disc Medicine Inc. (Watertown, Mass.). "Methods of treating erythropoietic protoporphyria, x-linked... और पढ़ें


US Patent Issued to Kyungpook National University Industry-Academic Cooperation Foundation on Sept. 1 for "Pharmaceutical composition for preventing or treating graft versus host disease comprising thiamine derivatives" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,848, issued on Sept. 1, was assigned to Kyungpook National University Industry-Academic Cooperation Foundation (Buk-gu daegu, South Korea). ... और पढ़ें


US Patent Issued to LIQMEDS WORLDWIDE on Sept. 1 for "Liquid oral formulations for PDE V inhibitors" (Indian Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,849, issued on Sept. 1, was assigned to LIQMEDS WORLDWIDE Ltd. (Weedon, Great Britain). "Liquid oral formulations for PDE V inhibitors" was... और पढ़ें


US Patent Issued to ENALARE THERAPEUTICS on Sept. 1 for "Large-conductance potassium channel modulators, compositions thereof, methods of manufacturing thereof, and methods of use thereof" (Arizona, Florida Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,850, issued on Sept. 1, was assigned to ENALARE THERAPEUTICS INC.. "Large-conductance potassium channel modulators, compositions thereof, m... और पढ़ें


US Patent Issued to Eisai R&D Management on Sept. 1 for "Pharmaceutical composition for treating solid tumors" (Japanese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,851, issued on Sept. 1, was assigned to Eisai R&D Management Co. Ltd. (Tokyo). "Pharmaceutical composition for treating solid tumors" was i... और पढ़ें


US Patent Issued to C4 Therapeutics on Sept. 1 for "Advantageous therapies for disorders mediated by Ikaros or Aiolos" (Massachusetts, Colorado Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,852, issued on Sept. 1, was assigned to C4 Therapeutics Inc. (Watertown, Mass.). "Advantageous therapies for disorders mediated by Ikaros o... और पढ़ें


US Patent Issued to SUN YAT-SEN UNIVERSITY, THE FIRST AFFILIATED HOSPITAL, SUN YAT-SEN UNIVERSITY on Sept. 1 for "Applications of CX-5461 in treating immune rejection in renal transplantation" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,853, issued on Sept. 1, was assigned to SUN YAT-SEN UNIVERSITY (Guangzhou, China) and THE FIRST AFFILIATED HOSPITAL, SUN YAT-SEN UNIVERSITY ... और पढ़ें


US Patent Issued to Theralase Technologies on Sept. 1 for "Inactivation of pathogens using metal-based coordination complexes, and methods and compositions for treating and preventing microbial and/or viral infections" (Canadian Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,854, issued on Sept. 1, was assigned to Theralase Technologies Inc. (Toronto). "Inactivation of pathogens using metal-based coordination co... और पढ़ें